United States · FDA National Drug Code directory

Divalproex Sodium

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
0832-7123_45afcbe0-c2e7-008a-e063-6394a90a111e
Product NDC
0832-7123
Form
TABLET, DELAYED RELEASE
Composition / generic term
Divalproex Sodium
Labeler
Upsher-Smith Laboratories, LLC
Marketing category
ANDA
Marketing start / end (source format)
20140321 / 20271031

Source-listed ingredients

  • DIVALPROEX SODIUM — 250 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 100 BLISTER PACK in 1 CARTON (0832-7123-01) / 1 TABLET, DELAYED RELEASE in 1 BLISTER PACK (0832-7123-89) · 0832-7123-01
  • 100 TABLET, DELAYED RELEASE in 1 BOTTLE (0832-7123-11) · 0832-7123-11
  • 500 TABLET, DELAYED RELEASE in 1 BOTTLE (0832-7123-15) · 0832-7123-15

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →